BRAIN Graphic
Equity Story

With BRAIN Biotech AG you invest in secular growth and sustainable success

Since the foundation of the company in 1993, BRAIN Biotech AG has developed from an R&D powerhouse to a truly integrated enterprise, which can offer the full value chain from the lab to production. We stay at the heart of the Bioeconomy creating breakthrough bioproducts and solutions for nutrition, health and the environment. We fully focus on the B2B segment.

Six reasons to invest in BRAIN Biotech AG

1. With our solutions we address the social trend towards more health and sustainability

→ more

2. We serve the concept of the bioeconomy and actively contribute to more sustainable industrial production

→ more

3. We are active in defensive end markets that offer structural growth

→ more

4. We combine a unique technology portfolio with enzymes, microorganisms and bioactive natural substances

→ more

5. We have a recognized partner network

→ more

6. We are active in markets with high barriers to market entry

→ more

IR Contact

Head of Investor Relations & Sustainability

IR Contact BRAIN AG

Investor Relations

Share this page